- Home
- AVIR vs XYF Comparison
AVIR vs XYF Comparison
Compare AVIR & XYF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AVIR | XYF |
|---|---|---|
| Founded | 2012 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 266.4M | 260.6M |
| IPO Year | 2020 | 2018 |
Fundamental Metrics
Financial Performance| Metric | AVIR | XYF |
|---|---|---|
| Price | $3.37 | $6.14 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 393.0K | 216.3K |
| Earning Date | 11-12-2025 | 11-20-2025 |
| Dividend Yield | N/A | ★ 9.26% |
| EPS Growth | N/A | ★ 49.84 |
| EPS | N/A | ★ 5.72 |
| Revenue | N/A | ★ $1,106,908,607.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $1.06 |
| Revenue Growth | N/A | ★ 47.14 |
| 52 Week Low | $2.46 | $5.44 |
| 52 Week High | $4.02 | $20.36 |
Technical Indicators
Market Signals| Indicator | AVIR | XYF |
|---|---|---|
| Relative Strength Index (RSI) | 53.27 | 35.94 |
| Support Level | $3.29 | $5.60 |
| Resistance Level | $3.63 | $6.15 |
| Average True Range (ATR) | 0.13 | 0.32 |
| MACD | -0.00 | 0.17 |
| Stochastic Oscillator | 45.53 | 52.95 |
Price Performance
Historical ComparisonAbout AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About XYF X Financial each representing six
X Financial is a Cayman Islands-based technology-driven personal finance company. Along with its subsidiaries, the firm provides diversified investment opportunities to investors in China through its wealth management platform, Xiaoying Wealth Management. Loan products offered by the company include Xiaoying Card Loan, Xiaoying Preferred Loan, and Xiaoying Housing Loan. The company generates revenue from loan facilitation service, post-origination service, and guarantee services provided.